The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Rationale for the use of somatostatin analogs as antitumor agents
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Reubi, J. C., & Waser, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1184-3 · Cited by 592
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
Hofland, L. J., & Lamberts, S. W. J. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0001 · Cited by 474
Karnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Molecular pharmacology of somatostatin receptor subtypes
Patel, Y. C. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03350317 · Cited by 409
Reubi, J. C., Kvols, L. K., Waser, B., Nagorney, D. M., Heitz, P. U., Charboneau, J. W., Reading, C. C., & Moertel, C. G. (1990) · PubMed · Cited by 375
Papotti, M., Bongiovanni, M., Volante, M., Allìa, E., Landolfi, S., Helboe, L., Schindler, M., Cole, S., & Bussolati, G. (2002) · Virchows Archiv · doi:10.1007/s00428-002-0609-x · Cited by 330
Homo- and Heterodimerization of Somatostatin Receptor Subtypes
Pfeiffer, M., Koch, T., Schröder, H., Klutzny, M., Kirscht, S., Kreienkamp, H., Höllt, V., & Schulz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006084200 · Cited by 319
Shimon, I., Taylor, J. E., Dong, J. Z., Bitonte, R. A., Kim, S., Morgan, B., Coy, D. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119225 · Cited by 309
Somatostatin Analogs in Acromegaly
Freda, P. U. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3013 · Cited by 298
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
Bevan, J. S., Atkin, S. L., Atkinson, A. B., Bouloux, P.-M., Hanna, F., Harris, P. E., James, R. A., McConnell, M., Roberts, G. A., Scanlon, M. F., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012012 · Cited by 279
Sharma, K. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1688 · Cited by 269
Gorden, P., Comi, R. J., Maton, P. N., & Go, V. L. W. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-1-35 · Cited by 258
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Somatostatin analogs in the diagnosis and treatment of cancer
Lamberts, S. W. J., de Herder, W. W., & Hofland, L. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00667-7 · Cited by 217
Shojamanesh, H., Gibril, F., Louie, A., Ojeaburu, J. V., Bashir, S., Abou‐Saif, A., & Jensen, R. T. (2002) · Cancer · doi:10.1002/cncr.10195 · Cited by 215
Kulaksiz, H., Eissele, R., Rössler, D., Schulz, S., Höllt, V, Cetin, Y., & Arnold, R. (2002) · Gut · doi:10.1136/gut.50.1.52 · Cited by 209
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
Buscail, L., Saint‐Laurent, N., Chastre, E., Vaillant, J., Gespach, C. P., Capellá, G., Kalthoff, H., Lluı́s, F., Vaysse, N., & Susini, C. (1996) · PubMed · Cited by 201
Self-citationCozzi, R., Attanasio, R., Montini, M., Pagani, G., Lasio, G., Lodrini, S., Barausse, M., Albizzi, M., Dallabonzana, D., & Pedroncelli, A. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030110 · Cited by 190
Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells
Patel, R. C., Kumar, U., Lamb, D. C., Eid, J. S., Rocheville, M., Grant, M., Rani, A., Hazlett, T., Patel, S. C., Gratton, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042705099 · Cited by 190
Hofland, L. J., van der Hoek, J., van Koetsveld, P. M., de Herder, W. W., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., Feelders, R., van der Lely, A.-J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031344 · Cited by 185
Colao, A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2779 · Cited by 179
Florio, T., Morini, M., Villa, V., Arena, S., Corsaro, A., Thellung, S., Culler, M. D., Pfeffer, U., Noonan, D. M., Schettini, G., et al. (2003) · Endocrinology · doi:10.1210/en.2002-220949 · Cited by 169
Saveanu, A., Gunz, G., Dufour, H., Caron, P., Fina, F., Ouafik, L., Culler, M. D., Moreau, J. P., Enjalbert, A., & Jaquet, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7099 · Cited by 168
Schmid, H. A., & Schoeffter, P. (2004) · Neuroendocrinology · doi:10.1159/000080741 · Cited by 168
Weckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
Murray, R. D., Kim, K., Ren, S.-G., Chelly, M. R., Umehara, Y., & Melmed, S. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19933 · Cited by 162
Identification of Human Mononuclear Leukocytes Bearing Receptors for Somatostatin and Glucagon
Bhathena, S. J., Louie, J., Schechter, G. P., Redman, R. S., Wahl, L., & Recant, L. (1981) · Diabetes · doi:10.2337/diab.30.2.127 · Cited by 160
Molecular Signaling of Somatostatin Receptors
Lahlou, H., Guillermet‐Guibert, J., Hortala, M., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.012 · Cited by 150
Molecular targets in pituitary tumours
Heaney, A. P., & Melmed, S. K. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1320 · Cited by 125
Elliott, D. E., Li, J., Blum, A. M., Metwali, A., Patel, Y., & Weinstock, J. V. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08<2454::aid-immu2454>3.0.co;2-h · Cited by 121
Benali, N. L., Cordelier, P., Calise, D., Pagès, P., Rochaix, P., Nagy, A., Estève, J., Pour, P. M., Schally, A. V., Vaysse, N., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130196697 · Cited by 120
Self-citationCaron, P. J., Arlot, S., Bauters, C. C., Chanson, P., Kuhn, J., PUGEAT, M. M., Maréchaud, R., Teutsch, C., Vidal, E., & Sassano, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7593 · Cited by 119
Antiproliferative Effect of Somatostatin and Analogs
Bousquet, C., Puente, E., Buscail, L., Vaysse, N., & Susini, C. (2001) · Chemotherapy · doi:10.1159/000049159 · Cited by 116
Self-citationInhibition of Angiogenesis by Somatostatin and Somatostatin-like Compounds Is Structurally Dependent
Barrie, R. J., Woltering, E. A., Hajarizadeh, H., Mueller, C., Ure, T., & Fletcher, W. S. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1167 · Cited by 104
90Y–DOTA– D ‐Phe1–Try3– octreotide in therapy of neuroendocrine malignancies
Paganelli, G., Bodei, L., Handkiewicz-Junak, D., Rocca, P. A., Papi, S., Sierra, M. L., Gatti, M., Chinol, M., Bartolomei, M., Fiorenza, M., et al. (2002) · Biopolymers · doi:10.1002/bip.10349 · Cited by 104
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
Delesque, N., Buscail, L., Estève, J. P., Saint‐Laurent, N., Müller, C., Weckbecker, G., Bruns, C., Vaysse, N., & Susini, C. (1997) · PubMed · Cited by 99
Self-citationA tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.
Kéri, G., Érchegyi, J., Horváth, A., Mező, I., Idei, M., Vántus, T., Balogh, A., Vadász, Z., Bökönyi, G., Seprődi, J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12513 · Cited by 99
Ayuk, J., Stewart, S. E., Stewart, P. M., & Sheppard, M. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011913 · Cited by 95
Ricci, S., Antonuzzo, A., Galli, L., Ferdeghini, M., Bodei, L., Orlandini, C., & Conte, P. (2000) · Annals of Oncology · doi:10.1023/a:1008383132024 · Cited by 90
Ren, S.-G., Kim, S., Taylor, J., Dong, J., Moreau, J.-P., Culler, M. D., & Melmed, S. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030302 · Cited by 85
Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
Cascinu, S., Fedeli, A., Fedeli, S. L., & Catalano, G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.148 · Cited by 85
Garland, J., Buscombe, J. R., Bouvier, C., Bouloux, P. M., Chapman, M. H., Chow, A. C., Reynolds, N., & Caplin, M. E. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01420.x · Cited by 83
Janson, E., Stridsberg, M., Gobl, A., Westlin, J.-E., & Öberg, K. (1998) · PubMed · Cited by 81
The Novel Somatostatin Ligand (SOM230) Regulates Human and Rat Anterior Pituitary Hormone Secretion
Murray, R. D., Kim, K., Ren, S.-G., Lewis, I., Weckbecker, G., Bruns, C., & Melmed, S. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031319 · Cited by 79
Romancer, M. L., Reyl-Desmars, F., Chérifi, Y., Pigeon, C.-A., Bottari, S. P., Meyer, O., & Lewin, M. J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32463-8 · Cited by 64
Leong, W. L., & Pasieka, J. L. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10062 · Cited by 63
Cattaneo, M. G., Taylor, J. E., Culler, M. D., Nisoli, E., & Vicentini, L. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02012-3 · Cited by 59
Somatostatin receptor distribution and function in immune system
Ferone, D., van Hagen, P. M., Semino, C., Dalm, V. A. S. H., Barreca, A., Colao, A. A. L., Lamberts, S. W. J., Minuto, F. M., & Hofland, L. J. (2003) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.11.020 · Cited by 58
Kiaris, H., Schally, A. V., Nagy, A., Szepesházi, K., Hébert, F., & Halmos, G. B. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00437-8 · Cited by 50
Medical Treatment of Metastasizing Carcinoid Tumors
Arnold, R. (1996) · World Journal of Surgery · doi:10.1007/s002689900031 · Cited by 48
Established Clinical Use of Octreotide and Lanreotide in Oncology
Öberg, K. (2001) · Chemotherapy · doi:10.1159/000049160 · Cited by 43
Inhibition of endothelial proliferation by the somatostatin analogue SOM230
Adams, R. L., Adams, I. P., Lindow, S. W., & Atkin, S. L. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02098.x · Cited by 42
Rogers, B. E., Zinn, K. R., Lin, C., Chaudhuri, T. R., & Buchsbaum, D. J. (2002) · Cancer · doi:10.1002/cncr.10300 · Cited by 41
Signal transduction of somatostatin in human B lymphoblasts
Rosskopf, D., Schürks, M., Manthey, I., Joisten, M., Busch, S., & Siffert, W. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00160.2001 · Cited by 40
Tulipano, G., Bonfanti, C., Milani, G., Billeci, B., Bollati, A., Cozzi, R. C., Maira, G., Murphy, W. A., Poiesi, C., Turazzi, S., et al. (2001) · Neuroendocrinology · doi:10.1159/000054651 · Cited by 39
Lin, C., Varma, M. G., Joubel, A., Madabushi, S., Lichtarge, O., & Barber, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212315200 · Cited by 36
Kumar, M., Liu, Z.-R., Thapa, L. B., Chang, Q., Wang, D.-Y., & Qin, R. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.393 · Cited by 35
Role of Amphiphysin II in Somatostatin Receptor Trafficking in Neuroendocrine Cells
Sarret, P., Esdaile, M. J., McPherson, P. S., Schönbrunn, A., Kreienkamp, H., & Beaudet, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310792200 · Cited by 24
Cited by
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Halfdanarson, T. R., Rabe, K. G., Rubin, J., & Petersen, G. M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn351 · Cited by 892
MODLIN, I. M., PAVEL, M., KIDD, M., & GUSTAFSSON, B. I. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04174.x · Cited by 410
Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
Fani, M., Maecke, H. R., & Okarvi, S. M. (2012) · Theranostics · doi:10.7150/thno.4024 · Cited by 333
Metadata
- Authors
- Susini, C., & Buscail, L.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 17
- Issue
- 12
- Pages
- 1733-1742
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2129462305
- Cited by
- 304
- References
- 67
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.